Avoro Capital Advisors LLC 13D and 13G filings for Centessa Pharmaceuticals plc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-05-15 08:19 am Sale | 2026-03-31 | 13G | CENTESSA PHARMACEUTICALS PLC S CNTA | Avoro Capital Advisors LLC | 11,430,455 7.390% | -3,125,100 (-21.47%) | Filing |
| 2026-02-17 09:04 am Purchase | 2025-12-31 | 13G | CENTESSA PHARMACEUTICALS PLC S CNTA | Avoro Capital Advisors LLC | 14,555,555 9.970% | 3,747,475 (+34.67%) | Filing |
| 2025-11-14 09:05 am Purchase | 2025-09-30 | 13G | CENTESSA PHARMACEUTICALS PLC S CNTA | Avoro Capital Advisors LLC | 10,808,080 8.060% | 10,808,080 (New Position) | Filing |